Current indications for post-mastectomy radiation

International Seminars in Surgical Oncology

Volumn 6, Issue , 2009, Pages

  Vilarino Varela, Maria ^a   Chin, Yaw Sinn ^b   Makris, Andreas ^a  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; TRASTUZUMAB;

AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER MORTALITY; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; HUMAN; LITERATURE; LYMPH NODE METASTASIS; MASTECTOMY; OVERALL SURVIVAL; POSTOPERATIVE CARE; REVIEW; RISK REDUCTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

EID: 61649113765     PISSN: None     EISSN: 14777800     Source Type: Journal    
DOI: 10.1186/1477-7800-6-5     Document Type: Review

References (26)

1. Ragaz J Jackson SM Le N Plenderleith IH Spinelli JJ Basco VE Wilson KS Knowling MA Coppin CM Paradis M Coldman AJ Olivotto IA Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer N Engl J Med 1997, 337(14):956-62 10.1056/ NEJM199710023371402 9309100
2. Overgaard M Hansen PS Overgaard J Rose C Andersson M Bach F Kjaer M Gadeberg CC Mouridsen HT Jensen MB Zedeler K Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial N Engl J Med 1997, 337(14):949-55 10.1056/NEJM199710023371401 9395428
3. Overgaard M Jensen MB Overgaard J Hansen PS Rose C Andersson M Kamby C Kjaer M Gadeberg CC Rasmussen BB Blichert-Toft M Mouridsen HT Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial Lancet 1999, 353(9165):1641-8 10.1016/ S0140-6736(98)09201-0 10335782
4. Overgaard M Nielsen HM Overgaard J Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials Radiother Oncol 2007, 82(3):247-53 10.1016/j.radonc.2007.02.001 17306393
5. Whelan TJ Julian J Wright J Jadad AR Levine ML Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis J Clin Oncol 2000, 18(6):1220-9 10715291
6. Cuzick J Stewart H Rutqvist L Houghton J Edwards R Redmond C Peto R Baum M Fisher B Host H et al Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy J Clin Oncol 1994, 12(3):447-53 8120544
7. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group Lancet 2000, 355(9217):1757-70 10.1016/S0140-6736(00)02263-7 10832826
8. Recht A Gray R Davidson NE Fowble BL Solin LJ Cummings FJ Falkson G Falkson HC Taylor SG 4th Tormey DC Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group J Clin Oncol 1999, 17(6):1689-700 10561205
9. Katz A Strom EA Buchholz TA Thames HD Smith CD Jhingran A Hortobagyi G Buzdar AU Theriault R Singletary SE McNeese MD Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation J Clin Oncol 2000, 18(15):2817-27 10920129
10. Wallgren A Bonetti M Gelber RD Goldhirsch A Castiglione-Gertsch M Holmberg SB Lindtner J Thürlimann B Fey M Werner ID Forbes JF Price K Coates AS Collins J International Breast Cancer Study Group Trials I through VII Risk factors for locoregional recurrence among breast cancer patients: Results from International Breast Cancer Study Group Trials I through VII J Clin Oncol 2003, 21(7):1205-13 10.1200/JCO.2003.03.130 12663706
11. Taghian A Jeong JH Mamounas E Anderson S Bryant J Deutsch M Wolmark N Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials J Clin Oncol 2004, 22(21):4247-54 10.1200/JCO.2004.01.042 15452182
12. Strom EA Woodward WA Katz A Buchholz TA Perkins GH Jhingran A Theriault R Singletary E Sahin A McNeese MD Clinical investigation: Regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy Int J Radiat Oncol Biol Phys 2005, 63(5):1508-13 10.1016/j.ijrobp.2005.05.044 16169678
13. Recht A Pierce SM Abner A Vicini F Osteen RT Love SM Silver B Harris JR Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma J Clin Oncol 1991, 9(6):988-96 2033433
14. Suneson BL Lindholm C Hamrin E Clinical incidence of lymphoedema in breast cancer patients in Jonkoping County, Sweden Eur J Cancer Care (Engl) 1996, 5(1):7-12 10.1111/j.1365-2354.1996.tb00199.x 8715464
15. Kwan W Jackson J Weir LM Dingee C McGregor G Olivotto IA Chronic arm morbidity after curative breast cancer treatment: Prevalence and impact on quality of life J Clin Oncol 2002, 20(20):4242-8 10.1200/ JCO.2002.09.018 12377968
16. Urban JA Marjani MA Significance of internal mammary lymph node metastases in breast cancer Am J Roentgenol Radium Ther Nucl Med 1971, 111(1):130-6 5540919
17. Morrow M Foster RS Jr Staging of breast cancer: A new rationale for internal mammary node biopsy Arch Surg 1981, 116(6):748-51 7016069
18. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials Lancet 2005, 365(9472):1687-717 10.1016/S0140-6736(05)66544-0 15894097
19. Gianni L Baselga J Eiermann W Guillem Porta V Semiglazov V Lluch A Zambetti M Sabadell D Raab G Llombart Cussac A Bozhok A Martinez-Agulló A Greco M Byakhov M Lopez Lopez JJ Mansutti M Valagussa P Bonadonna G European Cooperative Trial in Operable Breast Cancer Study Group Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer J Clin Oncol 2003, 21(6):976-83 10.1200/JCO.2003.02.063 12637460
20. Martin M Pienkowski T Mackey J Pawlicki M Guastalla JP Weaver C Tomiak E Al-Tweigeri T Chap L Juhos E Guevin R Howell A Fornander T Hainsworth J Coleman R Vinholes J Modiano M Pinter T Tang SC Colwell B Prady C Provencher L Walde D Rodriguez-Lescure A Hugh J Loret C Rupin M Blitz S Jacobs P Murawsky M Riva A Vogel C Breast Cancer International Research Group 001 Investigators Adjuvant docetaxel for node-positive breast cancer N Engl J Med 2005, 352(22):2302-13 10.1056/NEJMoa043681 15930421
21. Piccart-Gebhart MJ Procter M Leyland-Jones B Goldhirsch A Untch M Smith I Gianni L Baselga J Bell R Jackisch C Cameron D Dowsett M Barrios CH Steger G Huang CS Andersson M Inbar M Lichinitser M Láng I Nitz U Iwata H Thomssen C Lohrisch C Suter TM Rüschoff J Suto T Greatorex V Ward C Straehle C McFadden E Dolci MS Gelber RD Herceptin Adjuvant (HERA) Trial Study Team Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 2005, 353(16):1659-72 10.1056/ NEJMoa052306 16236737
22. Romond EH Perez EA Bryant J Suman VJ Geyer CE Jr Davidson NE Tan-Chiu E Martino S Paik S Kaufman PA Swain SM Pisansky TM Fehrenbacher L Kutteh LA Vogel VG Visscher DW Yothers G Jenkins RB Brown AM Dakhil SR Mamounas EP Lingle WL Klein PM Ingle JN Wolmark N Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer N Engl J Med 2005, 353(16):1673-84 10.1056/NEJMoa052122 16236738
23. Baum M Buzdar A Cuzick J Forbes J Houghton J Howell A Sahmoud T The ATAC (Arimidex, Tamoxifen Alone or in Combination) Trialists' Group Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: Results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses Cancer 2003, 98(9):1802-10 10.1002/cncr.11745 14584060
24. Coombes RC Hall E Gibson LJ Paridaens R Jassem J Delozier T Jones SE Alvarez I Bertelli G Ortmann O Coates AS Bajetta E Dodwell D Coleman RE Fallowfield LJ Mickiewicz E Andersen J Lønning PE Cocconi G Stewart A Stuart N Snowdon CF Carpentieri M Massimini G Bliss JM Velde van de C Intergroup Exemestane Study A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer N Engl J Med 2004, 350(11):1081-92 10.1056/ NEJMoa040331 15014181
25. Goss PE Ingle JN Martino S Robert NJ Muss HB Piccart MJ Castiglione M Tu D Shepherd LE Pritchard KI Livingston RB Davidson NE Norton L Perez EA Abrams JS Therasse P Palmer MJ Pater JL A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer N Engl J Med 2003, 349(19):1793-802 10.1056/ NEJMoa032312 14551341
26. Breast International Group (BIG) 1-98 Collaborative Group Thürlimann B Keshaviah A Coates AS Mouridsen H Mauriac L Forbes JF Paridaens R Castiglione-Gertsch M Gelber RD Rabaglio M Smith I Wardley A Price KN Goldhirsch A A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer N Engl J Med 2005, 353(26):2747-57 10.1056/NEJMoa052258 16382061